Cargando…
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
BACKGROUND: Severe asthma (SA) may require frequent courses or chronic use of oral corticosteroids (OCS), inducing many known side effects and complications. Therefore, it is important to identify risk factors of chronic use of OCS in SA, considering the heterogeneity of clinical and inflammatory as...
Autores principales: | Graff, S., Vanwynsberghe, S., Brusselle, G., Hanon, S., Sohy, C., Dupont, L. J., Peche, R., Michils, A., Pilette, C., Joos, G., Louis, R. E., Schleich, F. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424982/ https://www.ncbi.nlm.nih.gov/pubmed/32787967 http://dx.doi.org/10.1186/s12931-020-01460-7 |
Ejemplares similares
-
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
por: Hanon, Shane, et al.
Publicado: (2020) -
Variability in total serum IgE over 1 year in severe asthmatics
por: Louis, Renaud, et al.
Publicado: (2019) -
A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
por: Cataldo, Didier, et al.
Publicado: (2017) -
Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015) -
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth
por: Renner, Andreas, et al.
Publicado: (2020)